Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective
- PMID: 32249102
- PMCID: PMC7102520
- DOI: 10.1016/j.sapharm.2020.03.012
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective
Abstract
Background: The novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic.
Objective: To discuss community pharmacists' role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population.
Method: Collect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients' PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic.
Results: Community pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic.
Conclusion: PC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients' need. Community pharmacies shall work as a strong supporter of patient's medication and protective equipment supply. Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control.
Keywords: COVID-19; Community pharmacy; Novel coronavirus pneumonia; Pharmaceutical care; Safe medication use.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
To the best of our knowledge, the named authors have no conflict of interest, financial or otherwise, of the submitted work.
Figures
Similar articles
-
Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.Int J Clin Pharm. 2020 Aug;42(4):1197-1206. doi: 10.1007/s11096-020-01078-1. Epub 2020 Jun 11. Int J Clin Pharm. 2020. PMID: 32524513 Free PMC article.
-
Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey.Res Social Adm Pharm. 2021 Jan;17(1):1832-1837. doi: 10.1016/j.sapharm.2020.07.006. Epub 2020 Jul 9. Res Social Adm Pharm. 2021. PMID: 33317761 Free PMC article.
-
Pandemic preparedness of community pharmacies for COVID-19.Res Social Adm Pharm. 2021 Jan;17(1):1888-1896. doi: 10.1016/j.sapharm.2020.05.009. Epub 2020 May 11. Res Social Adm Pharm. 2021. PMID: 32417070 Free PMC article.
-
Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.Res Social Adm Pharm. 2021 Jan;17(1):1967-1977. doi: 10.1016/j.sapharm.2020.04.002. Epub 2020 Apr 10. Res Social Adm Pharm. 2021. PMID: 32389631 Free PMC article. Review.
-
Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations.Front Public Health. 2022 Jan 11;9:758325. doi: 10.3389/fpubh.2021.758325. eCollection 2021. Front Public Health. 2022. PMID: 35087781 Free PMC article.
Cited by
-
Cognitive, Behavioral, and Emotional Disorders in Populations Affected by the COVID-19 Outbreak.Front Psychol. 2020 Sep 16;11:2263. doi: 10.3389/fpsyg.2020.02263. eCollection 2020. Front Psychol. 2020. PMID: 33041902 Free PMC article. Review.
-
Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline.Chemosphere. 2021 Jul;275:129968. doi: 10.1016/j.chemosphere.2021.129968. Epub 2021 Feb 16. Chemosphere. 2021. PMID: 33652275 Free PMC article. Review.
-
Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence.Int J Environ Res Public Health. 2021 Feb 26;18(5):2302. doi: 10.3390/ijerph18052302. Int J Environ Res Public Health. 2021. PMID: 33652711 Free PMC article.
-
Impact of a clinical pharmacist on ultrasound-guided venous thromboembolism screening in hospitalized COVID-19 patients: a pilot prospective study.J Pharm Health Care Sci. 2021 Apr 1;7(1):19. doi: 10.1186/s40780-021-00201-2. J Pharm Health Care Sci. 2021. PMID: 33795030 Free PMC article.
-
COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.Res Social Adm Pharm. 2021 Jan;17(1):1913-1919. doi: 10.1016/j.sapharm.2020.07.037. Epub 2020 Aug 22. Res Social Adm Pharm. 2021. PMID: 32893134 Free PMC article.
References
-
- Chinese Pharmaceutical Association CORONAVIRUS SARS-CoV-2 INFECTION: Expert Consensus on guidance and prevention strategies for hospital pharmacists and the pharmacy workforce (2nd edition) [EB/OL]. [2020-03-03] http://www.cpa.org.cn/cpadmn/attached/file/20200216/1581854567839722.pdf
-
- International Pharmaceutical Federation CORONAVIRUS SARS-CoV-2 OUTBREAK: information and interim guidelines for pharmacists and the pharmacy workforce [EB/OL]. [2020-03-03] https://www.fip.org/file/4428
-
- National Health Commission of the People’s Republic of China Diagnosis and treatment plan for patients with novel coronavirus pneumonia (6th trial version) [EB/OL]. [2020-02-20] http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aef...
-
- Wei M., Chen Q., Yu D.M. The development of pharmaceutical care in domestic and foreign communities and its enlightenment on establishing pharmacy major in China [J] Chin Pharmaceut J. 2010;(12):98–100.
-
- Centers for Disease Control and Prevention Evaluating and reporting persons under investigation (PUI) [EB/OL]. [2020-03-04] https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical